Navigation Links
Meningitis Shot Available, Effective Year-Round
Date:10/25/2007

are given, and early treatment is important. Still, it does not guarantee a full recovery.

More information

To learn more about meningitis, visit the National Meningitis Association.



SOURCES: Donna Cary, spokeswoman, Sanofi Pasteur Inc., Swiftwater, Penn.; Lynn Bozof, executive director, National Meningitis Association, Marietta, Ga.


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Meningitis C vaccine a cost-effective success
2. Cure for Bacterial Meningitis
3. Efficacy Of Meningitis C Vaccine
4. Meningitis is rocking the capital again
5. New warning signs for child meningitis
6. Uganda Tackles The Meningitis Outbreak
7. Fatal Case of Meningitis Detected In Massachusetts
8. Meningitis Back in Delhi and 21 Dead
9. New Delhi Hit By Meningitis Deaths
10. Cost-effective Meningitis Vaccine To Be Launched In Africa
11. Delhi Witnessed 34 Meningitis Deaths In Three Months
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Abbott Announces TCT 2009 Activities 57402 1Abbott Announces TCT 2009 Activities 57402 2Abbott Announces TCT 2009 Activities 57402 3Abbott Announces TCT 2009 Activities 57402 4Abbott Announces TCT 2009 Activities 57402 5PharmAbcine Closes USD 246 Million Series A Financing 14102 1PharmAbcine Closes USD 246 Million Series A Financing 14102 2PharmAbcine Closes USD 246 Million Series A Financing 14102 3PharmAbcine Closes USD 246 Million Series A Financing 14102 4The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 1The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 2